+1-617-394-8820 contact@baybiosciences.com

Bay Biosciences provides high quality, clinical grade tumor tissue samples FFPE Blocks with matched serum (sera), plasma and peripheral blood mononuclear cells (PBMC) biofluid samples from treatment-naive patients newly diagnosed with Renal Cell Carcinoma (RCC). Samples processed under customized protocols provided by the customer. The serum (sera), plasma and PBMC biofluid samples are processed from Renal Cell Carcinoma (RCC) untreated patient’s fresh whole-blood from unique untreated patients diagnosed with Renal Cell Carcinoma (RCC).

Detailed clinical data and pathology annotations including patient’s corresponding diagnostic test values associated with Renal Cell Carcinoma (RCC) tumor tissue samples and matched serum (sera), plasma and PBMC biofluid samples are provided to a valued pharmaceutical customer for research.

Renal cell carcinoma (RCC) Overview

Renal cell carcinoma (RCC) is also called hypernephroma, renal adenocarcinoma, or renal or kidney cancer. It’s the most common kind of kidney cancer found in adults.

The kidneys are organs in your body that help get rid of waste while also regulating fluid balance. There are tiny tubes in the kidneys called tubules. These help filter the blood, aid in excreting waste, and help make urine. RCC occurs when cancer cells start growing uncontrollably in the lining of the tubules of the kidney. RCC is a fast-growing cancer and often spreads to the lungs and surrounding organs.

Renal cell carcinoma (RCC) Causes

The exact causes of Renal cell carcinoma (RCC) are unknown. RCC cancer mostly develops in men between the ages of 50 and 70 but can be diagnosed in anyone.

Following are some of the common risk factors for the Renal cell carcinoma (RCC) disease: